Cobimetinib Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. COBIMETINIB (koe bi me ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat certain types of melanoma, a skin cancer. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. Cobimetinib Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Cobimetinib Nitroso CAS NO:NA chemically represented as (S)-(3,4-Difluoro-2-((2-fluoro-4-iodophenyl)amino)phenyl)(3-hydroxy-3-(1-nitrosopiperidin-2-yl)azetidin-1-yl)methanone. Synchemia is the leading manufacturing and exporter of Cobimetinib Nitroso . We supply Cobimetinib Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142804 |
| CAS No | NA |
| Mol.F. | C17H16Cl2N2O4 |
| Mol.Wt. | 383.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142805 |
| CAS No | NA |
| Mol.F. | C18H18N2O2 |
| Mol.Wt. | 294.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142806 |
| CAS No | NA |
| Mol.F. | C18H18N2O2 |
| Mol.Wt. | 294.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142807 |
| CAS No | NA |
| Mol.F. | C18H20N2O3 |
| Mol.Wt. | 312.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142808 |
| CAS No | NA |
| Mol.F. | C18H18N2O2 |
| Mol.Wt. | 294.35 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142809 |
| CAS No | NA |
| Mol.F. | C9H12N2O2 |
| Mol.Wt. | 180.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142810 |
| CAS No | NA |
| Mol.F. | C15H20N2O3 |
| Mol.Wt. | 276.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142811 |
| CAS No | NA |
| Mol.F. | C15H20N2O2 |
| Mol.Wt. | 260.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142812 |
| CAS No | NA |
| Mol.F. | C15H22N2O2 |
| Mol.Wt. | 262.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142813 |
| CAS No | NA |
| Mol.F. | C15H10ClN3O2 |
| Mol.Wt. | 299.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142814 |
| CAS No | NA |
| Mol.F. | C16H12ClN3O2 |
| Mol.Wt. | 313.74 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142815 |
| CAS No | NA |
| Mol.F. | C25H22ClN3O3 |
| Mol.Wt. | 447.92 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142816 |
| CAS No | NA |
| Mol.F. | C14H12ClN3O |
| Mol.Wt. | 273.72 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142817 |
| CAS No | NA |
| Mol.F. | C10H12N2O3S2 |
| Mol.Wt. | 272.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142818 |
| CAS No | NA |
| Mol.F. | C10H15N3O5S3 |
| Mol.Wt. | 353.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142819 |
| CAS No | NA |
| Mol.F. | C10H13N3O6S3 |
| Mol.Wt. | 367.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |